Synthesis and biological activity

Medicinal chemists working at the intersection of organic synthesis and pharmacology design and build heterocyclic compounds—ring-shaped molecules containing atoms such as nitrogen, oxygen, or sulfur—to understand how small structural changes translate into measurable biological effects. Much of the current effort centers on molecules like chalcones, coumarins, and pyrazoles, which have shown promise as anticancer agents by disrupting tubulin polymerization or starving tumors of their blood supply through vascular targeting. Researchers are actively trying to understand why certain scaffolds bind selectively to disease-relevant proteins while sparing healthy tissue, and how synthetic modifications can sharpen that selectivity without sacrificing potency or introducing toxicity. Open questions include how to move the most promising candidates reliably from in vitro screens into animal models, and how to exploit the structural versatility of heterocycles to address cancers that have developed resistance to existing therapies.

Works

98,880

Total citations

921,271

Keywords

Heterocyclic CompoundsMedicinal ChemistryAnticancer AgentsTubulin InhibitorsVascular Targeting AgentsChalcones